-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KlYFH2oX0AYm8ZpLSNBkvnx6fCfZnBxncsczLVWkO2sBwSME0IVQB5XCcKphMiSY q7P7aqF/zfVivWBGsgfA1A== 0000096313-97-000110.txt : 19970717 0000096313-97-000110.hdr.sgml : 19970717 ACCESSION NUMBER: 0000096313-97-000110 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961231 FILED AS OF DATE: 19970716 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: GULL LABORATORIES INC /UT/ CENTRAL INDEX KEY: 0000832404 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870404754 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11952 FILM NUMBER: 97641601 BUSINESS ADDRESS: STREET 1: 1011 E MURRAY HOLLADAY ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84117 BUSINESS PHONE: 8012633524 MAIL ADDRESS: STREET 1: 1011 EAST MURRAY HOLLADAY ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84117 10-K/A 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A [x] Amendment No. 3 to Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (Fee Required) for the Fiscal Year Ended December 31, 1996. or [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to ___________. Commission File Number 0-16864 GULL LABORATORIES, INC. ------------------------- (Exact Name of Registrant as Specified in its Charter) UTAH 87-0404754 ----------- ----------------- (State of Incorporation) (IRS Employer Identification Number) 1011 E. Murray Holladay Road Salt Lake City, UT 84117 ------------------------------ ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number: (801) 263 - 3524 Securities registered under Section 12(b) of the Exchange Act: Common Stock $.001 par value registered on the American Stock Exchange Securities registered under Section 12(g) of the Exchange Act: None Indicate by check/mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the proceeding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past ninety days. [x] Yes [ ] No Indicate by check/mark if disclosure of delinquent filers pursuant to Item 405 of Regulation 5K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ] The aggregate market value of the voting stock of the registrant held by non-affiliates of the registrant as of March 17, 1997 was $21,784,940 based upon the closing price on such date. The number of shares of common stock outstanding as of March 17, 1997 was 6,588,696. Documents Incorporated by reference: None -1- Item 6: Selected Consolidated Financial Data of the Registrant's Form 10-K for the Fiscal Year ended December 31, 1996 is hereby amended to read in its entirety as follows: ITEM 6: SELECTED CONSOLIDATED FINANCIAL DATA The following table sets forth selected consolidated financial information with respect to the Company for the periods indicated. This information should be read in conjunction with the Company's consolidated financial statements and related notes and "Management's Discussion and Analysis of Financial Condition and Results of Operations" appearing herein. - ------------------------------------------------------------------------------ Statement of Operations (000's Omitted) - ------------------------------------------------------------------------------ Year Ended December 31, - ------------------------------------------------------------------------------ 1996 1995 1994 1993 1992 ---------------------------------------------- Sales $17,909 $18,828 $15,842 $15,406 $14,646 Net Income (loss) 241* 212* (311) (401) (507) Net income (loss) per common and common equivalent share 0.04 0.03 (0.05) (0.06) (0.08) - ------------------------------------------------------------------------------ *See "1996 Compared to 1995" in "Results of Operations" below. There were no cash dividends declared in the periods presented above. - ------------------------------------------------------------------------------ Balance Sheet Data (000's Omitted) - ------------------------------------------------------------------------------ Year Ended December 31, - ------------------------------------------------------------------------------ 1996 1995 1994 1993 1992 ----------------------------------------------- Working capital $ 2,740 $ 125 $ 1,910 $ 2,064 $ 933 Total assets 12,353 12,318 11,502 10,446 11,336 Total long-term obligations 2,786 132 2,478 2,347 3,549 Stockholder's equity 4,975 4,741 4,080 4,493 3,177 - ------------------------------------------------------------------------------ -2- Signatures Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GULL LABORATORIES, INC. Date: July 15, 1997 By: /s/ George R. Evanega ---------------------------- George R. Evanega, Ph.D. President and CEO -3- Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. /s/ George R. Evanega Date: July 15, 1997 - ----------------------------------------- George R. Evanega President and Chief Executive Officer (Principal Executive Officer) Director /s/ Michael B. Malan Date: July 15, 1997 - ----------------------------------------- Michael B. Malan Secretary/Treasurer (Principal Financial & Accounting Officer) /s/ Myron W. Wentz Date: July 15, 1997 ----------------------------------------- Myron W. Wentz Chairman of the Board of Directors Date: ----------------------------------------- ------------------ Matthias Schmidt Director, Vice Chairman /s/ Gerd Krick Date: July 15, 1997 ----------------------------------------- Gerd Krick Director /s/ Ulrich Wagner Date: July 15, 1997 ----------------------------------------- Ulrich Wagner Director ___________________________________________ Date:____________________ Anne-Marie Ricart Director ___________________________________________ Date:___________________ Peter Gladkin Director -4- -----END PRIVACY-ENHANCED MESSAGE-----